Sign In
test

Ken Joseph

Braidwell Lp

Assets Managed
$2.998B
Holdings
88
Last Quarter
2026 - Q1
Filed Date
1mo 4d ago
Growth Rate
-4.13%(2Q avg: -5.67%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Braidwell Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 88 positions.

Assets under management

The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.998B in assets, with a quarterly growth rate of -4.13% and a 2-quarter average growth rate of -5.67%. The portfolio is managed by Ken Joseph, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
CAI
Caris Life Sciences Inc
Recent Activity
Increased 2.48%
4.78%
$143.209M
8.009M shares@ $17.88 avg price
ur-9⤦
Guardant Health Inc
Recent Activity
Decreased -41.86%
3.43%
$102.576M
60.954M shares@ $1.69 avg price
ur-8⤦
Repligen Corp
Recent Activity
3.3%
$98.677M
101M shares@ $0.98 avg price
ur-3⤦
Neogenomics Inc
Recent Activity
3.07%
$91.849M
100.381M shares@ $0.92 avg price
NBIX
Neurocrine Biosciences Inc
Recent Activity
Decreased -13.22%
2.87%
$85.91M
652,121 shares@ $131.75 avg price
GKOS
Glaukos Corp
Recent Activity
Decreased -17.18%
2.75%
$82.199M
763,505 shares@ $107.66 avg price
CNTA
Centessa Pharmaceuticals-adr
Recent Activity
Decreased -9.21%
2.64%
$78.914M
1.987M shares@ $39.73 avg price
XENE
Xenon Pharmaceuticals Inc
Recent Activity
Decreased -26.66%
2.6%
$77.831M
1.338M shares@ $58.16 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
Decreased -29.4%
2.52%
$75.475M
899,364 shares@ $83.93 avg price
EWTX
Edgewise Therapeutics Inc
Recent Activity
Decreased -54.94%
2.47%
$73.949M
2.348M shares@ $31.51 avg price

1-10 of 88